Comparative analysis of allergic rhinitis in children and adults

Current Allergy and Asthma Reports

Volumn 13, Issue 2, 2013, Pages 142-151

  Izquierdo Domínguez, Adriana ^a   Valero, Antonio L ^b   Mullol, Joaquim ^b  

^a Quiron Hospital   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Adults; Allergic rhinitis; Children; Classification; Clinical features; Comparative analysis; Epidemiology; Immunotherapy; Management; Prevalence; Quality of life

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MOMETASONE FUROATE; MONTELUKAST; ALLERGEN;

ACUPUNCTURE; ALLERGIC RHINITIS; ANOSMIA; ARTICLE; CHOANA ATRESIA; CLINICAL FEATURE; COMPARATIVE STUDY; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENCEPHALOMENINGOCELE; EPIPHORA; FOREIGN BODY; HOMEOPATHY; HUMAN; IMMUNOTHERAPY; NASAL PRURITUS; NOSE OBSTRUCTION; OCULAR PRURITUS; PATIENT EDUCATION; PHOTOTHERAPY; PREVALENCE; QUALITY OF LIFE; RHINITIS; RHINORRHEA; SLEEP DISORDERED BREATHING; SNEEZING; SYMPTOMATOLOGY; TERATOMA; ADULT; CHILD; INFANT; PERENNIAL RHINITIS; PRESCHOOL CHILD; REVIEW;

ADULT; ALLERGENS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; PREVALENCE; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL;

MLCS; MLOWN;

EID: 84876345946     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-012-0331-y     Document Type: Article

References (76)

1. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62 Suppl 5:17-25.
2. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc. 2007;28:3-9.
3. Morais-Almeida M, Gaspar A, Pires G, Prates S, Rosado Pinto J. Risk factors for asthma symptoms at school age: an 8-year prospective study. Allergy Asthma Proc. 2007;28:183-9.
4. Annesi-Maesano I, Hulin M, Lavaud F, et al. Poor air quality in classrooms related to asthma and rhinitis in primary schoolchildren of the French 6 cities study. Thorax. 2012;67:682-8.
5. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy. 2008;63 Suppl 86:8-160.
6. Valero A, Ferrer M, Sastre J, et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the allergic rhinitis and its impact on asthma severity items. J Allergy Clin Immunol. 2007;120:359-65.
7. Valero A, Ferrer M, Baró E, et al. Discrimination between moderate and severe disease may be used in patients witheither treated or untreated allergic rhinitis. Allergy. 2010;65(12):1609-13.
8. • Jáuregui I, Dávila I, Sastre J, et al. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: the PEDRIAL study. Pediatr Allergy Immunol. 2011;22:388-92. This article shows the validation of ARIA classification in children with allergic rhinitis.
9. • Montoro J, Del Cuvillo A, Mullol J, et al. Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: the PEDRIAL study. Allergy. 2012;67(11):1437-42. This article shows the validation of the modified ARIA severity classification in children with allergic rhinitis which discriminates moderate from severe disease among untreated patients.
10. Bousquet J, Bodez T, Gehano P, et al. Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial. Int Arch Allergy Immunol. 2009;150(1):75-82.
11. Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Prevalence, classification and perception of allergic and non allergic rhinitis in Belgium. Allergy. 2006;61:693-8.
12. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758-64.
13. Nathan RA, Meltzer EO, Derebery J, et al. The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. Allergy Asthma Proc. 2008;29:600-8.
14. Jessen M, Malm L. Definition, prevalence and development of nasal obstruction. Allergy. 1997;52 Suppl 40:3-6.
15. • Katelaris CH, Lee BW, Potter PC, et al. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clin Exp Allergy. 2012;42:186-207. This manuscript presents the latest prevalences of allergic rhinitis in developed countries and in both children and adults.
16. Asher MI, Keil U, Anderson HR, et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8:483-91.
17. Weiland SK, Björksten B, Brunekreef B, et al. Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J. 2004;24:406-12.
18. Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW, the ISAAC Steering Committee. The International Study of Asthma and Allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis. 2005;9:10-6.
19. Ait-khaled N, Odhiambo J, Pearce N, et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14- year- old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy. 2007;62:247-58.
20. Strachan D, Sibbald B, Weiland S, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC). Paediatr Allergy Immunol. 1997;8:161-76.
21. Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999;103:125-38.
22. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733-43.
23. Björksten B, Clayton T, Ellwood P, Stewart A, Strachan D, the ISAAC Phase Three Study Group. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol. 2008;19:110-24.
24. Ait-Khaled A, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J, ISAAC Phase Three Study Group. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) phase three. Allergy. 2009;64(1):123-48.
25. Lødrup Carlsen KC, Söderström L, Mowinckel P, et al. Asthma prediction in school children; the value of combined IgE antibodies and obstructive airways disease severity score. Allergy. 2010;65:1134-40.
26. Hopper JL, Jenkins MA, Carlin JB, Giles GG. Increase in the self-reported prevalence of asthma and hay fever in adults over the last generation: a matched parent-offspring study. Aust J Public Health. 1995;19:120-4.
27. Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy. 2005;60:350-3.
28. Cingi C, Topuz B, Songu M, et al. Prevalence of allergic rhinitis among the adult population in Turkey. Acta Otolaryngol. 2010;130:600-6.
29. Zhang L, Han D, Huang D, et al. Prevalence of self-reported allergic rhinitis in eleven major cities in China. Int Arch Allergy Immunol. 2009;149:47-57.
30. Neffen H, Mello JF, Sole D, et al. Nasal allergies in the Latin American population: results from the Allergies in Latin America survey. Allergy Asthma Proc. 2010;31 Suppl 1:S9-S23.
31. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol. 2007;19:23-34.
32. Del Cuvillo A, Montoro J, Bartra J, et al. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients-the ADRIAL cohort study. Rhinology. 2010;48(2):201-5.
33. Guilemany JM, Garcia-Piñeiro A, Alobid I, et al. Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation. Laryngoscope. 2009;119(2):233-8.
34. Hadley JA, Schaefer SD. Clinical evaluation of rhinosinusitis: history and physical examination. Otolaryngol Head Neck Surg. 1997;117:S8-S11.
35. Irwin RS. Silencing chronic cough [see comments]. Hosp Pract. 1999;34:53-60. quiz 129-30.5.
36. Kulig M, Klettke U, Wahn V, Forster J, Bauer CP, Wahn U. Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol. 2000;106:832-9.
37. Selnes A, Nystad W, Bolle R, Lund E. Diverging prevalence trends of atopic disorders in Norwegian children. Results from three cross sectional studies. Allergy. 2005;60:894-9.
38. Berger WE. Allergic rhinitis in children: diagnosis and management strategies. Paediatr Drugs. 2004;6:233-50.
39. Steele RW. Rhinosinusitis in children. Curr Allergy Asthma Rep. 2006;6:508-12.
40. Noone PG, Leigh MW, Sannuti A, et al. Primary ciliar dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med. 2004;169:459-67.
41. Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European community respiratory health survey. BMJ. 2002;325:411-4.
42. Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma [see comments]. N Engl J Med. 1997;336:1356-63.
43. Lewis SA, Weiss ST, Platts-Mills TA, Burge H, Gold DR. The role of indoor allergen sensitization and exposure in causing morbidity in women with asthma. Am J Respir Crit Care Med. 2002;165:961-6.
44. Chen WY, Tseng HI, Wu MT, et al. Synergistic effect of multiple indoor allergen sources on atopic symptoms in primary school children. Environ Res. 2003;93:1-8.
45. Shaaban R, Zureik M, Soussan D, et al. Allergic rhinitis and onset of bronchial hyperresponsiveness: a population-based study. Am J Respir Crit Care Med. 2007;176:659-66.
46. Rochat MK, Illi S, Ege MJ, et al. Allergic rhinitis as a predictor for wheezing onset in school-aged children. J Allergy Clin Immunol. 2010;126:1170-5-e2.
47. Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372:1049-57.
48. Camelo-Nunes I, Sole D. Allergic rhinitis: indicators of quality of life. J Bras Pneumol. 2010;36(1):124-33.
49. Gentile D, Shapiro G, Sloner D. Allergic rhinitis. In: Leung D, Sampson H, Geha R, Szefler S, editors. Pediatric allergy. Principles and practice. St. Louis: Mosby; 2003. p. 287-97.
50. Hallstrand TS, Curtis JR, Aitken ML, Sullivan SD. Quality of life in adolescents with mild asthma. Pediatr Pulmonol. 2003;36:536-43.
51. Roberts G, Mylonopoulou M, Hurley C, Lack G. Impairment in quality of life is directly related to the level of allergen exposure and allergic airway inflammation. Clin Exp Allergy. 2005;35:1295-300.
52. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007;120:381-7.
53. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009;124:S43-70.
54. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol. 1994;93(2):413-23.
55. Juniper EF, Howland WC, Roberts NB. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol. 1998;101:163-70.
56. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21:77-83.
57. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin Exp Allergy. 2000;30(1):132-40.
58. Juniper E, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in and adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2003;111:484-90.
59. Valero A, Alonso J, Antepara I, et al. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: the ESPRINT questionnaire. Val Health. 2007;10(6):466-77.
60. Valero A, Alonso J, Antépara I, et al. Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnaires. Allergy. 2007;62(12):1372-8.
61. Valero A, Baró E, Sastre J, et al. Reference values for facilitating the interpretation of the ESPRINT-15 questionnaire (Spanish version). J Investig Allergol Clin Immunol. 2009;19(5):396-403.
62. Valero A, Izquierdo I, Giralt J, et al. Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients. J Investig Allergol Clin Immunol. 2011;21(3):229-35.
63. Valero A, Muñoz-Cano R, Sastre J, et al. The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification. Rhinology. 2012;50(1):33-6.
64. Sardana N, Craig T. Congestion and sleep impairment in allergic rhinitis. Asian Pac J Allergy Immunol. 2011;29:297-306.
65. Derebery J, Meltzer E, Nathan RA, et al. Rhinitis symptoms and comorbidities in the United States: Burden of rhinitis in America survey. Otolaryngol Head Neck Surg. 2008;139:198-205.
66. Mullol J. A survey of the burden allergic rhinitis in Spain. J Investig Allergol Clin Immunol. 2009;19(1):27-34.
67. Marinho S, Simpson A, Custovic A. Allergen avoidance in the secondary and tertiary prevention of allergic diseases: does it work? Prim Care Respir J. 2006;15:152-8.
68. Filon FL, Radman G. Latex allergy: a follow up study of 1040 healthcare workers. Occup Environ Med. 2006;63:121-5.
69. Fink RS, Pierre LN, Daley Yates PT, Richards DH, Gibson A, Honour JW. Hypothalamic-pituitaryadrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation. J Clin Endocrinol Metab. 2002;87:4541-6.
70. Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol. 2012;22(1):1-12.
71. •• Brozek JL, Bousquet J, Baena-Cagnani CE, Global Allergy and Asthma European Network, Grading of Recommendations Assessment, Development and Evaluation Working Group, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-76. This manuscript shows the GRADE-based ARIA recommendations on the prevention and treatment of adults and children with allergic rhinitis, with and without comorbid asthma.
72. Schünemann HS, Jaeschke R, Cook DJ, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006;174:605-14.
73. Brozek JL, Baena-Cagnani CE, Bonini S, et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy. 2008;63:38-46.
74. Calderon M, Gerth van Wijk R, Eichler I, et al. Perspectives on allergen-specific immunotherapy in childhood: An EAACI position statement. Pediatr Allergy Immunol. 2012;23:300-6.
75. European Declaration on Immunotherapy: Combating Allergy Beyond Symptoms. http://eaaci.net/eaacimedia/1663-eaacipresents-theeuropean-declaration- onallergen-immunotherapy.
76. Calderon M, Cardona V, Demoly P, on behalf of the EAACI 100 Years of Immunotherapy Experts Panel. One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions. Allergy. 2012;67:462-76.